CTOs on the Move

Connect Hearing

www.connecthearing.com

 
We provide a strong network of convenient neighborhood hearing care centers across the country that continually strives to find innovative ways to serve you better. Our Hearing Care Professionals are passionate about helping people to hear better, applying a consistent process to determine the best recommendations for your hearing health. We provide free next day evaluations with professional recommendations based upon your inidiviudal hearing needs and lifestyle. We offer a walk-in, walk-out 2-week FREE trial with hearing aids that are right for you - plus the Connect Advantage, your assurance Connect Hearing will be there every step of the way. Headquartered in the Chicago ...
  • Number of Employees: 0-25
  • Annual Revenue: > $1 Billion

Executives

Name Title Contact Details
Sven Davies
 Vice President of Information Technology Profile

Similar Companies

AGFA HealthCare Corporation

AGFA HealthCare Corporation is a Greenville, SC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Amarex Clinical Research

Amarex offers more than capable hands. We are a consultative group of clinical researchers, always ready to go out 'on the limb' and give our own recommendations for solving the challenges clients face over the course of a clinical development program or

Optalis

Optalis Health & Rehabilitation is a company that provides post-hospital rehabilitation care, skilled nursing care, and assisted living care in South Eastern Michigan and the Columbus, Ohio area.

Weber and Weber International GmbH and Co.

Weber and Weber International GmbH and Co. is a Orlando, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Geron

We are a biopharmaceutical company developing first-in-class therapies for cancer. Imetelstat, a novel, first-in-class telomerase inhibitor, is our product candidate in clinical development. Telomerase enables cancer cells to maintain telomere length, which provides them with the capacity for limitless cellular replication. Imetelstat is a potent and specific inhibitor of telomerase. Based on clinical data we obtained in late 2012, we may develop imetelstat to treat one or more hematologic myeloid malignancies such as myelofibrosis, or MF, myelodysplastic syndromes, or acute myelogenous leukemia.